text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2021.12.31\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n(주)티움바이오\n상장\n2019.04.30\n투자\n3,000\n240,000\n1.01\n5,064\n-115,000\n-3,077\n426\n125,000\n0.53\n2,413\n85,351\n-12,119\n일성신약(주)\n상장\n2006.06.05\n투자\n930\n1,000\n0.04\n83\n-\n-\n-9\n1,000\n0.04\n74\n371,225\n3,220\n한국제약협동조합\n비상장\n1978.04.04\n공동출자\n162\n663\n6.26\n162\n-\n-\n-\n663\n6.26\n162\n11,670\n-306\n씨씨알(주)\n비상장\n2005.01.02\n투자\n74\n13,489\n0.32\n18\n-\n-\n-18\n13,489\n0.32\n0\n9,042\n2,487\n(주)퓨어스피어\n비상장\n2016.11.03\n투자\n300\n3,000\n6.52\n218\n-\n-\n-\n3,000\n6.52\n218\n10,483\n1,279\n프리미어 글로벌 이노베이션1호 투자조합\n비상장\n2017.06.15\n투자\n560\n-\n4\n4,394\n-\n-902\n-828\n-\n4\n2,663\n99,189\n24,256\n라이프코어-이앤 신기술 사업투자조합 1호\n비상장\n2017.08.10\n투자\n500\n-\n12.2\n500\n-\n-\n-\n-\n12.2\n500\n1,175\n-263\n수성코스닥벤처 멀티에셋공모주 사모투자신탁 2호\n비상장\n2018.06.07\n투자\n1,000\n0\n0\n1,663\n-\n-1,663\n-\n0\n-\n0\n1,050\n13,828\n수성코스닥벤처 M6 전문투자형 사모투자신탁\n비상장\n2020.10.16\n투자\n2,000\n0\n0\n2,085\n-\n-\n294\n0\n-\n2,379\n106\n861\n(주)클리노믹스\n상장\n2018.07.20\n투자\n1,000\n138,928\n1.04\n2,410\n-\n-\n-611\n138,928\n1.04\n1,799\n43,760\n-13,146\n시너지 바이오 헬스케어 벤처펀드\n비상장\n2019.05.16\n투자\n601\n0\n0\n1,401\n-\n367\n-\n0\n-\n1,768\n28,200\n185\n보고신기술사업금융전문투자형 사모투자신탁 제2호\n비상장\n2019.06.04\n투자\n1,000\n0\n0\n1,296\n-\n-\n-556\n0\n-\n740\n21,667\n8,420\nDS Benefit,XV 전문투자형 사모투자신탁\n비상장\n2020.05.29\n투자\n300\n0\n0\n300\n-\n-\n-\n0\n-\n300\n300\n5,816\n주식회사 엘베이스\n비상장\n2020.12.28\n투자\n2,000\n93,053\n5.97\n2,000\n-\n-\n-\n93,053\n5.97\n2,000\n2,000\n1,664\n프리미어 글로벌 이노베이션 2호 투자조합\n비상장\n2020.11.03\n투자\n250\n0\n0\n250\n-\n2,265\n-107\n0\n-\n2,408\n2,000\n4,500\n엠투엔 제14회차 사모 전환사채\n비상장\n2021.06.28\n투자\n1,017\n0\n0\n0\n-\n1,017\n-\n0\n-\n1,017\n2,263\xa0\n-1,242\n신보2021제14차유동화전문회사 제1-3회 무보증후순위공모사채\n비상장\n2021.08.27\n투자\n270\n0\n0\n-\n-\n270\n-\n-\n-\n270\n2,263\xa0\n1,242\xa0\nNH 앱솔루트 코스닥벤처 메자닌 1호\n비상장\n2021.09.23\n투자\n2,000\n0\n0\n-\n-\n2,000\n-49\n-\n-\n1,951\n11,870\xa0\n1,809\xa0\n더블유피 기술혁신 스타트업 2호 조합(*)\n비상장\n2021.11.19\n투자\n200\n0\n0\n0\n-\n200\n-\n-\n-\n200\n-\n-\n디지털 이노베이션 벤처투자조합(*)\n비상장\n2021.12.16\n투자\n3,000\n0\n0\n0\n-\n3,000\n-\n-\n29.24\n3,000\n-\n-\n대원메디테크(주)\n비상장\n2011.04.12\n경영참여\n2,300\n2,799,999\n64.42\n0\n-\n-\n-\n2,799,999\n64.24\n-\n674\xa0\n261\xa0\n(주)다나젠\n비상장\n2015.12.11\n경영참여\n40\n679,184\n28.6\n1,040\n-\n-\n-\n679,184\n28.6\n1,040\n28,825\xa0\n2,583\xa0\nDAEWON PHARMACEUTICAL (Vietnam) Co., Ltd.\n비상장\n2017.07.31\n경영참여\n430\n0\n100\n836\n-\n-\n-\n0\n100\n836\n-\n-\n극동에치팜 주식회사\n비상장\n2021.05.26\n경영참여\n14,114\n0\n0\n0\n60,553\n14,602\n-\n60,553\n83.51\n14,602\n28,825\n-2,583\n합 계\n-\n-\n23,720\n-54,447\n18,079\n-1,458\n-\n-\n40,340\n-\n-\n주) 상기표 총자산, 당기순손익은 2020년도 기준임 *) 더블유피 기술 혁신 스타트업 2호 조합, 디지털 이노베이션 벤처투자조합은 2021년 12월 출시로 2020년도 재무 현황 기재를 생략함\n']"
